Anzeige
Mehr »
Dienstag, 24.03.2026 - Börsentäglich über 12.000 News
Das "Next Butte?"-Setup in Montana - und es ist noch immer eine $15M-Story
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoJefferies reiterates Supernus Pharmaceuticals stock Buy rating
MoJefferies reiterates Grab stock rating on Taiwan foodpanda deal
MoCantor Fitzgerald cuts Robinhood stock price target on revenue outlook
MoBarclays lowers Alvotech stock price target to $4 on approval timing
MoKratos wins contract for SKY Perfect JSAT 5G satellite network
MoRBC Capital reiterates Ideaya Biosciences stock rating on trial delay
MoGuggenheim raises Cabaletta Bio stock price target on trial progress
MoOSB Group executives receive share-based compensation awards
MoCantor Fitzgerald upgrades Coeur Mining stock rating to buy
MoBarclays reiterates Simon Property stock rating after CEO death
MoAllegiant offers fee-free changes amid government shutdown
MoBofA raises WeRide stock price target on overseas robotaxi growth
MoBofA raises Insmed stock price target on positive trial data
MoGuggenheim reiterates Buy rating on Avalo Therapeutics stock
MoZillow becomes official MLB partner in multiyear deal
MoMaaT Pharma presents phase 3 trial results for aGvHD treatment
MoBarclays raises Viatris stock price target on pipeline potential
MoStifel reiterates Buy rating on Limbach Holdings stock at $107
MoApogee Therapeutics stock holds at Hold as trial data beats views
MoBofA raises Northern Oil and Gas price target to $32 on leverage outlook
MoRBC Capital raises Insmed stock price target on ENCORE trial results
MoApple schedules WWDC for June 8-12 with AI focus
MoTurkcell secures $1 billion Islamic financing for 5G rollout
MoAdvent to sell 5.6% stake in Trustpilot via accelerated placing
MoJefferies raises Pyxis Oncology stock price target on drug data